Halberd Co. (OTCMKTS:HALB) Sees Large Decline in Short Interest

Halberd Co. (OTCMKTS:HALB) saw a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 1,500 shares, a decrease of 94.3% from the June 30th total of 26,400 shares. Based on an average daily trading volume, of 834,300 shares, the short-interest ratio is currently 0.0 days.

Halberd Price Performance

Shares of HALB traded up $0.00 during mid-day trading on Friday, reaching $0.01. 2,224,846 shares of the company were exchanged, compared to its average volume of 1,322,866. The business has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01. Halberd has a 52 week low of $0.00 and a 52 week high of $0.01.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.